v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses        
Research and development expenses $ 48,293 $ 44,873 $ 136,299 $ 135,256
Selling, general and administrative expenses 5,962 7,025 21,510 23,122
Total operating expenses 54,255 51,898 157,809 158,378
Operating loss (54,255) (51,898) (157,809) (158,378)
Gain (Loss) from warrant liability 997 6,441 3,890 285
Financial investment income 4,255 4,144 14,063 11,598
Interest expense (5,544) (2,671) (15,392) (7,293)
Other loss, net (523) (1,657) (5,639) (5,446)
Loss before income taxes (55,071) (45,641) (160,888) (159,234)
Income tax expense (benefit) 2,982 1,225 206 1,102
Net loss $ (58,052) $ (46,866) $ (161,094) $ (160,336)

Source